PHARMACOTHERAPY OF CEREBRAL EDEMA

Authors

  • Abdukakhorova Rukhshona Nodirovna.,
  • Abdurakhmonova. Zamira Ergashboevna

Keywords:

To analyze pharmacotherapeutic approaches to the correction of cerebral edema based on the results of our research and analysis of the literature.

Abstract

Edema and swelling of the brain (OCS) is one of the main causes of mortality in traumatic brain
injury [1], neuroinfections, and liver failure [2, 14]. Also, cerebral edema is observed with tumors
of the central nervous system, cerebral circulatory disorders, intoxication, and complicates some
mental and infectious diseases, renal failure, and hypoxic conditions [3]. For example, mortality
in severe traumatic brain injury (TBI) reaches 70% [4], while, according to various authors,
swelling and dislocation of the brain are the main cause of death (about 40% of cases) [5,6].
Therefore, ONGM remains one of the main problems of intensive care.

Downloads

Published

2024-05-24

How to Cite

Rukhshona Nodirovna., , A., & Zamira Ergashboevna, A. (2024). PHARMACOTHERAPY OF CEREBRAL EDEMA. American Journal of Pediatric Medicine and Health Sciences (2993-2149), 2(5), 220–226. Retrieved from https://grnjournal.us/index.php/AJPMHS/article/view/4898

Issue

Vol. 2 No. 5 (2024): American Journal of Pediatric Medicine and Health Sciences

Section

Articles